MedCAC Supports Some PGx Test Regimens, But Calls For Overall Better Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Most studies still are not supplying sufficient data on patient outcomes for genetic and protein-based tests designed to drive medical treatments, the Medicare Evidence Development & Coverage Advisory Committee agreed.